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Abstract 
In order to scientifically appraise some of the anecdotal, folkloric, 
ethno medical uses of Pisonia aculeata Linn. (Nyctaginaceae), the 
present study was undertaken to examine the antitumor activity of 
methanolic extract of Pisonia aculeata leaves extract on Ehrlich Ascites 
Carcinoma (EAC) in mice. Tumor was induced in mice by 
intraperitoneal injection of Ehrlich Ascites Carcinoma cells (1X10 6 
cells/mouse). Methanolic extract of Pisonia aculeata (MPA) was 
administered to the experimental animals at the doses of 200 & 400 
mg/kg/day, p.o. The antitumor effect of the extract was evaluated by 
using survival time, haematological parameters, increase in body 
weight, solid tumor volume and peritoneal cell count. Oral 
administration of MPA increased the survival time and inhibits the 
weight gain of the tumor bearing mice. After 14 days of inoculation, the 
extract also reduces the solid tumor volume developed by the EAC 
cells. The findings of this study indicate that the MPA possesses 
significant antitumor activity on dose dependent manner. 
Keywords: Pisonia aculeata, ehrlich ascites carcinoma, tumor. 
 
Introduction 
The majority of the world's population in 
developing countries still relies on herbal 
medicines to meet their health needs in cases 
when synthetic medicine could not relieve 
patients who suffer from hard to cure illnesses 
like cancer. A number of natural products have 
been studied for anticancer activity on various 
experimental models. This has resulted in the 
availability of nearly 30 effective anticancer 
drugs[1]. Plant derived compounds, in particular 
have a special place in anti-cancer therapy, and 
some of the new chemotherapeutic agents 
currently available for use in a clinical setting 
include paclitaxel, vincristine, podophyllotoxin 
and camptothecin, a natural product precursor for 
water soluble derivatives [2–4]. Due to lack of 
effective drugs, cancer is a fatal disease rating the 
top three cause of death. Many of the 
chemotherapeutic agents sold for the treatment of 
cancer are highly expensive, mutagenic, 
carcinogenic and teratogenic and marrow 
inhibition limits their applications [5]. Therefore 
the quest for effective anti-cancer drug is an 
active research field. Efforts, therefore, are being 
made to identify naturally occurring 
anticarcinogens, which would prevent, 
slow/reverse cancer development [6].  
 
Pisonia aculeata Linn. (Nyctaginaceae) is a large 
scandent shrub, which holds an important place 
in folklore medicine. It is extensively used by 
native medical practitioners and tribes for treating 
swelling, rheumatic pains, jaundice and tumors 
[7]. Preliminary phytochemical screening of the 
extract showed the presence of alkaloids, 
triterpenes, phenolic compounds, flavonoids and 
glycosides. However no studies to date have been 
able to demonstrate the pharmacological 
activities. The present study is focused on 
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evaluation of the anticancer activity of the 
methanolic extract of leaves of Pisonia aculeata 
(MPA) against Ehrlich Ascites carcinoma in 
mice. 
 
Material And Methods 
Collection and extraction of plant material 
Fresh leaves of Pisonia aculeata were collected 
from the surrounding of Tirupati district(517502), 
AndhraPradesh, India, in the month of April and 
May 2010 and authenticated by Dr. K. Madhava 
Chetty, Asst. Professor, Department of  Botany, 
Sri Venkateswara University, Tirupati 
AndhraPradesh ,India. 
 
The leaves were shade dried and pulverized. The 
powder was treated with petroleum ether for 
dewaxing and removal of chlorophyll. Later it 
was packed (250 g) in soxhlet apparatus and 
subjected to continuous hot percolation for 8 h 
using 450 ml methanol (70% v/v) as solvent. The 
methanolic extract was concentrated under 
vacuum and dried in a desicator (yield 12.5 g, 5 
% w/w). Without any purification, aliquot 
portions of the crude extract were suspended in 
5% gum acacia for use on each day of our 
experiment.The Phytochemical studies were 
performed as described by Wagner et al, 1984. 
The extract showed the presence of alkaloids, 
triterpenes, phenolic compounds, flavonoids and 
glycosides. 
 
Animals Used 
Swiss albino mice (20-25g) were used 
throughout the study.  They were housed in 
standard microlon boxes and were given 
standard laboratory diet and water ad libitum. 
Each cage contained 6 rats of the same sex 
with a bedding of husk, and 12-hour 
light/dark cycles were provided. 
Environmental conditions were maintained at 
a temperature of 22°C ± 2°C and a relative 
humidity of 60% ± 10%. 
 
 
Tumor cell lines   
Dalton’s ascitic lymphoma (DAL) cells were 
obtained through the courtesy of Amala Cancer 
Research Centre, Thrissur, Kerala. DAL cells 
were maintained by weekly intraperitoneal (i.p) 
inoculation of 1×106 cells / mouse. 
 
Effect of MPA on survival time 
Animals were inoculated with 1 × 106 
cells/mouse on day ‘0’ and treatment with MPA 
started 24 h after inoculation, at the doses of 200 
& 400 mg/kg/day  orally.  The control group was 
treated with same volume of 0.9% sodium 
chloride solution.  All treatments were carried out 
for 9 days and observation was carried out for 45 
days. The animals were subjected for the analysis 
of median survival time (MST) of DAL group 
(n=6) and changes in body weight. The antitumor 
efficacy of MPA (200 & 400 mg/kg/day p.o.) was 
compared with that of 5-Fluorouracil (20 
mg/kg/day i.p. for 9 days). MST was noted with 
reference to control. Survival times of the treated 
group (T) were compared with those of the 
control groups (C) using the following 
calculation. 
Increase in life span = T-C / C × 100 
Where T = number of days treated animals 
survived and C = number of days control animal 
survived.  
 
Effect of MPA on haemotological parameters 
In order to detect the influence of MPA on the 
haemotological status of DAL bearing mice, 
comparison was made amongst six groups (n= 6) 
of mice on the 14th day after inoculation.  The 
four groups comprised (1) tumor bearing mice, 
(2-3) tumor bearing mice treated with MPA 
respectively (200 & 400 mg/kg/day p.o. for first 9 
days) and (4) control mice.  Blood was drawn 
from DAL mouse in the conventional way and 
the white blood cell count, red blood cell count, 
haemoglobin, protein and differential leukocyte 
counts were determined. The ascitic fluids were 
collected on 14th day and smeared. The smear 
was stained with Giemsa stain for cytological 
studies.   
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Fig A.Tumor Control 
Tumor cells are large in size. It shows with sheet of lymphoma with nucleation. 
 
                          
Fig. B & C-Treated with MPA  
(200 mg/kg) Shows large lymphoma cell with high n/c ratio. Some of them show cytoplasmic  vacuolation. 
 
 
               
Fig. D&E-Treated with MPA  
(400mg/kg) Shows Plasmacytoid feature with varying degree of degeneration,  cytoplasmic vacuolation  and also showed 
active  mitosis. 
Fig 1. Cytological Studies –Dalton’s Ascites Lymphoma. 
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The liver was removed and preserved in tris HCl 
buffer pH [7.4]. A 10% liver homogenate was 
used for antioxidant studies such as tissue lipid 
peroxidation (LPO) superoxide dismutase (SOD), 
catalase, glutathione peroxidase (GPX), 
glutathione S-Transferase (GST).  
 
Effect of MPA on normal peritoneal cells 
Five groups of normal mice (n= 5) were used for 
the study.  Two groups received a single 
administration of MPA at 200 & 400 mg/kg, p.o.  
The 3rd and 4th groups received the same 
treatment for two consecutive days.  The 
untreated 5th group was used as control. Cells of 
peritoneal exudates were collected 24 h after 
treatment by repeated intraperitoneal wash with 
normal saline and counted in each of the 
treatment groups and compared with those of the 
untreated groups. 
 
Effect of MPA on solid tumor  
Mice were divided into three groups (n=6). 
Tumor cells (1×106 cells / mice) were injected 
into the right hind limb of all the animals 
intramuscularly. Mice of group I were tumor 
control. Group II to III received MPA 
respectively (200 & 400mg/kg, p.o.) for 5 
alternate days. Tumor mass was measured from 
11th day of tumor induction and was repeated 
every 5th day for a period of 30 days. The volume 
of tumor mass was calculated using the formula 
V = 4/3 π r2 where r is the mean of r1 and r2 
which are two independent radii of the tumor 
mass. 
 
Cytotoxicity of MPA by tryphan blue dye 
exclusion method 
Trypan blue is recommended in dye Exclusion 
procedures for viable cell counting based on the 
principle that live (viable) cells actively pump out 
the dye by efflux mechanism where as dead (non-
viable) cells do not. Cytotoxicity was assessed by 
incubating  1 × 106 DAL cells in 1 ml phosphate 
buffer saline with varying concentrations(25-400 
μg/ml) of the  MPA  at 370 C for 3 h in CO2 
atmosphere. The viability of the cells was 
determined by trypan blue exclusion method. In 
this method dead cells take up the dye where as 
viable cell exclude the dye. The percentage of 
dead cells was calculated from which the IC50 
concentration was determined. 
 
% Inhibition = No of stained cells / No of 
stained + no of unstained cell X 10        
 
Statistical analysis 
All the values were expressed as mean ± SEM. 
The data was statistically analyzed by one-way 
ANOVA followed by Dunnett’s test. The data of 
haematological, and antioxidant parameters were 
analyzed using ANOVA followed by Tukey 
multiple comparison test.  P values < 0.05 were 
considered significant.  
 
Results and Discussion 
The methanolic extract was prepared by using 
soxhlet apparatus and the yield was found to be 
12.5 g, 5 % w/w. Preliminary phytochemical 
analysis of MPA showed the positive test for 
alkaloids, triterpenes, phenolic compounds, 
flavonoids and glycosides. 
 
Antitumor studies 
Mean Survival Time (MST) 
Any potential anticancer drug is expected to 
increase the mean survival time and thus 
increasing life expectancy[8]. Mice transplanted 
with DAL in our studies have MST of 16 days, 
which was increased to 23 & 29 days by MPA 
respectively (200 and 400 mg/kg). These results 
are almost comparable to that of 5-FU, the 
standard drug for which the MST was 32 days 
(Table 1). 
 
Changes in Body Weight 
There is a tendency for increase in body weight in 
tumor bearing mice, which is the result of 
increased formation and collection of ascitic 
fluid. Potential anticancer drugs decrease this 
increased body weight by decreasing the 
formation of ascites and this effect is due to the 
cytotoxicity against malignant cells, which 
induce ascites. Tumor bearing mice showed an 
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increase in body weight to the extent of 14.92 g. 
The increase in body weight was considerably 
less on treatment with MPA (200 & 400 mg/kg). 
The effect is almost 50% of that produced by 5-
FU the standard drug tested. In DAL bearing 
mice, the body weight of control animal was 
14.92 g. The increased body weight was reduced 
significantly (P<0.01) to 8.76 and 7.05g 
respectively on treatment with MPA (200 & 400 
mg/kg) (Table 1). 
 
Table 1 :  Effect of MPA treatment on the survival and Average Body weight Changes of Tumor Bearing Mice. 
Treatment MST (d) Life Span (%) Average increase in body wt (g) 
Tumor control              
(Saline 2 ml/kg, p.o.) 
16 ± 1. 15 - 14.92 ± 1.27  
5-FU (20 mg/kg, i.p.) 32 ± 1.02a 100 5.45 ± 0.86 a 
MPA (200 mg/kg p.o) 23 ± 1.18 a 43.75 8.76 ± 0.53 a 
MPA (400 mg/kg p.o) 29 ± 1.56 a 81.25 7.05 ± 0.95 a 
n = 6 animals; Days of drug treatment = 9 
aP< 0.01  Vs Tumor control  
Data were analyzed by using one way ANOVA followed by Dunnett  test. 
 
Table 2 : Effect of MPA (200 & 400 mg/kg  p.o.)  on Haemotological Parameters. 
Differential Count % Treatment Hb (g%) RBC (million/mm3)
WBC 
(103cells/mm3)
Proteins (g 
%) Lymphocytes Neutrophils Monocytes
Normal mice  14.7 ± 0.58 4.5 ± 0.17 8.2 ± 0.54 7.8 ± 0.26 72 ± 1.5 26 ± 1.2 2 ± 0 
Tumor bearing  
mice (14 days) 8.3 ± 0.67a 2.6 ± 0.08 a 20.8 ± 1.67 a 12.7 ± 1.15 a 23 ± 1.8 a 76 ± 1.4 a 1 ± 0 
10.7 ± 1.06 b 3.4 ± 0.32b,f 15.7 ± 0.86 a,f 11.2 ± 0.14b 64 ± 1.6 c,d 34 ± 1.7 b,d 2 ± 0 MPA 
(200 mg/kg,p.o) 
400 mg/kg, p.o 12.6 ± 0.53 e 4.2 ± 0.16 d 11.9 ± 1.06d 8.9 ± 0.16 e 69 ± 2.4d 30 ± 1.6 d 1 ± 0 
n = 6;  Days of drug treatment = 9;  Values are expressed as mean ± SEM. 
aP < 0.001; bP < 0.01; cP< 0.05   Vs Normal mice    
dP < 0.001; eP< 0.01;  fP< 0.05  Vs Tumor mice. 
Data were analysed by one way ANOVA followed by Tukey multiple comparison test 
 
Table 3. Effect of MPA (200 & 400 mg/kg  p.o.)  on LPO, Antioxidants and GST Levels in DAL-Induced   Tumor 
Bearing Mice. 
Treatment Dose  
(mg/kg) 
LPO SOD Catalase GPx GST 
Normal (saline) 2 ml/kg 7.13 ± 0.54 4.15 ± 0.12 45 ± 0.78 8.05 ± 1.04     1.36 ± 0.07 
Tumor control - 20.65 ± 1.73 a 1.32 ± 0.35a 18 ± 0.53 a 3.64 ± 0.65 c 3.82 ± 0.26 a 
200 15.12 ± 0.67 a,e 2.35 ± 0.14 a,e 26 ± 0.64 a,d 4.93 ± 0.37 b 2.16 ± 0.13 b,dMPA  
400 11.08 ± 0.82 d 3.46 ± 0.17 d 37 ± 0.96 a,d 6.87 ± 0.52 f 3.29 ± 0.18 a 
N = 6; values are expressed as mean ± SEM.  
aP < 0.001; bP < 0.05; cP < 0.01 Vs. Normal 
dP < 0.001; eP < 0.01; fP< 0.05  Vs. Tumor Control 
 
Data were analysed by one way ANOVA followed by Tukey multiple comparison test 
LPO -  μ moles of MDA/ min/mg protein 
SOD -  units/min/mg protein 
CAT -  μ mole of H2O2 consumed/ min/mg protein 
GPx -  μ moles of GSH oxidised/min /mg protein 
        GST -  μ MOLES OF CDNB CONJUGATION FORMED/MIN /MG PROTEIN 
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Haematological Parameters 
In malignancy there is always an alteration of 
various haematological parameters which 
increase in a few and decrease in others. There is 
a decrease in Hb, RBC and lymphocytes in 
malignancy accompanied by an increase in WBC 
especially neutrophils, and protein (Table 2). 
These changes are due to iron deficiency or due 
to haemolytic of myelopathic conditions induced 
by malignancy. MPA have very well reverted the 
above haematological parameters altered by the 
transplantable tumor of DAL.  MPA may have 
direct tumoricidal DAL effect and thereby 
maintain normal haematological profile. 
 
Effect of MPA on Lipid Peroxidation 
The levels of lipid peroxidation in liver tissue 
were significantly increased (Table 3), by 20.65 ± 
1.73, in DAL control group as compared to the 
normal group (P<0.001). After administration of 
MPA at different doses   (200 and 400 mg/kg) to 
DAL bearing mice the levels of lipid peroxidation 
were reduced by 15.12 ± 0.67 and 11.08 ± 0.87 
respectively as compared to DAL control group  
(P < 0.001).  
 
Effect of MPA on Antioxidants 
The levels of superoxide dismutase (SOD) in the 
liver of DAL bearing mice decreased (P<0.001) 
in comparison with normal group. After 
administration of MPA at the dose of 200 and 
400 mg/kg increased levels of SOD significantly 
when compared to that of DAL control group 
(P<0.001). The catalase (CAT) level in DAL 
control group decreased (P<0.001) compared 
with normal group. Treatment with MPA at the 
dose of 200 and 400 mg/kg significantly 
increased CAT levels respectively on dose 
dependent manner when compared to that of 
DAL (P<0.001; P<0.01) 
 
Inoculation with DAL drastically decreased the 
GST and GPx content in DAL control group as 
compared with normal group (P < 0.001). 
Administration of MPA  at doses of 200 and 400 
mg/kg to the  DAL bearing mice increased GST 
and GPx levels respectively as compared with 
DAL control group (P<0.001; P<0.05) (Table 3). 
 
Peritoneal Cell Count  
The tendency for cancer cells is to decrease the 
peritoneal cell count whereas it is increased in 
normal animals or those treated with anticancer 
drugs. The implication of this is as discussed 
later. MPA (200 & 400 mg/kg)  increase 
peritoneal cell count in normal mice treated with 
these MPA extract for one day and two days 
(Table 4). Increase in peritoneal cell count 
induced by MPA is an indirect indication of their 
anticancer property. 
 
Table 4. Effect of MPA (200 & 400 mg/kg  p.o.)  
treatment on enhancement of peritoneal cell count  in 
normal mice. 
Number of peritoneal 
cells (1 × 106) / mouse 
Experiment 
200 mg/kg 400 mg/kg 
Control  4.1 ± 0.12 4.1 ± 0.31 
Treated once  5.6 ± 0.23 6.5 ± 0.25a 
Treated twice on two 
consecutive days 
7.2 ± 1.10 a 7.9 ± 0.68 a
N = 5/group; Values are expressed as mean ± SEM.   
aP < 0.01 Vs Control. 
Data were analyzed by using one way ANOVA followed 
by Dunnett  test. 
 
Table 5 : Effect of MPA (200 & 400 mg/kg p.o.)  on solid tumor volume. 
Solid tumor volume (ml) Treatment Dose (mg/kg) 15th day 20th day 25th day 30th day 
Tumor control - 3.15 ± 0.12 4.08 ± 0.27 4.98 ± 0.23 5.96 ± 0.32 
200 2.56 ± 0.36 3.41 ± 0.15b 3.90 ± 0.12a 4.62 ± 0.11a MPA 
400 2.23 ± 0.15b 3.30 ± 0.11b 3.67 ± 0.19 a 4.25 ± 0.41a 
 N = 6 animals; Values are expressed as mean ± SEM. 
 aP<0.01; bP<0.05  Vs Tumor Control. 
  Data were analyzed by using one way ANOVA followed by Dunnett  test. 
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Solid tumor volume and short-term 
cytotoxicity 
Estimation of solid tumor volume is a direct 
method of evaluation of anticancer activity. It is 
indeed a suitable method, which does not involve 
sacrificing the animal. In the study, the tumor 
mass was directly measured after implantation 
intramuscularly. The solid tumor volume was 
increased by 5.96 ± 0.32 in DAL bearing mice, 
treatment with MPA decreased significantly 
(P<0.01, P<0.05), the tumor volume to 4.62 ± 
0.11 and 4.25 ± 0.24 ml respectively on dose 
dependent manner at the end of 30 days (Table 
5).  The antitumor effect of MPA is very well 
evident from these observations.  
 
Table 6 : Cytotoxicity Effect of MPA on DAL by 
Tryphan Blue Dye Exclusion assay. 
Concentrations 
(µg/ml) 
% cell  
viability 
% cell  
death 
IC 50 
(µg/ml) 
25 81.4 18.6 
50 68.6 31.4 
100 57.5 42.5 
200 40.3 59.7 
400 23.8 76.2 
135 
Average of 3 determinations, 3 replicates   
IC50, Drug concentration inhibiting 50% cellular growth 
following 3 h of   drug exposure. 
 
Short term cytotoxicity studies by trypan blue 
exclusion method is a very simple method which 
can be carried out within a short time of 3 hrs. It 
is a precise method, which takes in to account the 
viable and also the dead cells in addition to 
estimation of IC50 concentration. The short term 
in vitro cytotoxicity study showed the IC50 of 
MPA to be 135 μg /ml.  MPA produced 
concentration dependent inhibition of cell growth 
on DAL. 
 
Discussion 
The reliable criteria for evaluating an anticancer 
drug are prolongation of lifespan of the animal 
[8] and decrease in WBC count of blood [9].  Our 
results show an increase in life span accompanied 
by a reduction in WBC count in MPA treated 
mice. These results clearly demonstrate the 
antitumor effect of MPA against DAL and this 
fact is further supported by an increase in 
peritoneal cell count. Treatment with MPA in 
DAL being mice caused a significant (P<0.01) 
decrease in the body weight. This may be due to 
the cytotoxic effect of these extract. These effects 
are comparable to that of 5-FU, the standard 
drug. 
 
Increase in peritoneal cell count is a proof and an 
indirect evidence for anticancer activity and this 
method has been used by other workers for 
anticancer studies [10,11]. This effect is 
presumed to be due to enhancement and 
activation of macrophages or through 
modification of cytokine product in peritoneal 
cavity. In the same line, the anticancer activity of 
MPA is evident in our studies by increase in 
peritoneal cell count induced in normal mice. The 
common problems encountered in cancer 
chemotherapy are myelosuppression and anaemia 
[12,13].  Anaemia occurring in tumor bearing 
mice is mainly due to reduction in RBC or 
haemoglobin production, and this may occur 
either due to iron deficiency or due to haemolytic 
or other myelopathic conditions [14]. Treatment 
with MPA  brought back the haemoglobin 
content, RBC and WBC counts to near normal. 
This indicates that MPA  have a protective effect 
on the haemopoietic system. Further, analysis of 
haemotological parameters showed minimum 
toxic effect in mice treated with MPA. In DAL 
bearing mice, haematological parameters were 
reversed to normal by MPA  administration (9 
days). 
 
Cytological studies of ascitic fluid on the 14th day 
in DAL bearing mice revealed that the tumor 
cells are large in size showed binucleation. In 
MPA  200 mg/kg treated animals bearing DAL, 
the cells showed high n/c ratio, plasmocytoid 
feature and cytoplasmic vacuolation. In MPA  
400 mg/kg treated animals bearing DAL, the 
cells, showed  plasmacytoid feature with varying 
degree of degeneration, cytoplasmic vacuolation 
and also showed active mitosis. All these 
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cytological studies indicate the cytotoxic effect of 
MPA. 
 
Excessive production of free radicals resulted in 
oxidative stress, which leads to damage of 
macromolecules such as lipids, and can induce 
lipid peroxidation in vivo[15]. Increased lipid 
peroxidation causes degeneration of tissue. Lipid 
peroxide formed in the primary site is be 
transferred through the circulation and provokes 
damage by propagating the process of lipid 
peroxidation.[16] Malondialdehyde, the end 
product of lipid peroxidation has been reported to 
be higher in carcinomatous tissue than in non 
diseased organs [17]. Glutathione, a potent 
inhibitor of neoplastic process, plays an important 
role as an endogenous antioxidant system that is 
found particularly in high concentrations in liver 
and is known to have key functions in the 
protective process . 
 
The free radical scavenging system, SOD and 
catalase are present in all oxygen metabolizing 
cells and their function is to provide a defence 
against the potentially damaging reactivates of 
superoxide and hydrogen peroxide[18] reported a 
decrease in SOD activity in DAL bearing mice 
which might be due to loss of Mn SOD activity in 
DAL cells and loss of mitochondria, leading to a 
decrease in total SOD activity in the liver. The 
inhibition of SOD and CAT activities as a result 
of tumor growth was also   reported[14]. Similar 
findings were observed in the present 
investigation with DAL bearing mice. Plant 
derived extracts containing antioxidant principles 
should cytotoxicity towards tumor cells[19] and 
antitumor activity in experimental animals[20]. 
The lowering of lipid peroxidation, and increases 
in levels of SOD, catalase GST and GPx in MPA  
treated groups indicates its potential as an 
inhibitor of DAL induced intracellular oxidative 
stress. Antitumor activity of these antioxidants is 
either through induction of apoptosis [21] or by 
inhibition of neovascularization [22]. The 
involvement of free radicals in tumors is well 
documented [23,24].   
 
In DAL -bearing mice, there was a regular and 
rapid increase in ascitic fluid volume. Ascitic 
fluid is the direct nutritional source for tumor 
growth; it meets the nutritional requirements of 
tumor cells [25].  MPA treatment decreased the 
volume of solid tumor and the viable cancer cell 
count, and increased the lifespan. It may be 
concluded that MPA decreases the nutritional 
fluid volume and thereby arrests tumor growth 
and increases the lifespan. There was a reduction 
in solid tumor volume in mice treated with MPA 
(P<0.001). The present study reveals that the 
extract was cytotoxic towards DAL. 
 
Plants have played an important role as a source 
of effective anticancer agents, and it is significant 
that 60% of currently used anticancer agents are 
derived from natural sources, including plants, 
marine organisms, and microorganisms.[26,27]  
Plant-based medicine has definitely found a role 
in cancer treatment (chemotherapy), and the 
mechanism of interaction between many 
phytochemicals and cancer cells has been studied 
extensively.[28] In particular, there is growing 
interest in the pharmacological evaluation of 
various plants used in, Indian traditional system 
of medicine. 
 
Plant-derived natural products such as flavonoids, 
terpenoids, and steroids, etc. have received 
considerable attention in recent years due to their 
diverse pharmacological properties, including 
antioxidant and antitumor activity [29,30]. 
Antioxidants play an important role in inhibiting 
and scavenging radicals, thus providing 
protection to humans against infection and 
degenerative diseases.  
 
Moreover, they have a chemopreventive role in 
cancer through their effects on signal 
transduction in cell proliferation [31]. and 
angiogenesis [32]. All these observations clearly 
indicate a significant antitumor and cytotoxic 
effect of the extract of the leaves of MPA. 
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Conclusion 
The antitumor effect of the extract was evaluated 
by using survival time, haematological 
parameters, increase in body weight, solid tumor 
volume and peritoneal cell count. It was found 
that the oral administration of MPA increased the 
survival time and inhibits the weight gain of the 
tumor bearing mice. After 14 days of inoculation, 
the extract also reduces the solid tumor volume 
developed by the EAC cells. The findings of this 
study indicate that the MPA possesses significant 
antitumor activity on dose dependent manner. 
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